CIDRAP newsletters options
About 27% of kids hospitalized for COVID-19 or MIS-C had symptoms 2 to 4 months later.
Only 86% of New York City preschoolers have received the recommended 3 doses of polio vaccine.
COVID-19 patients early in the pandemic had 4% higher healthcare use in the 6 months after illness onset than matched controls, most notably for infection-related conditions, hair loss, bronchitis, pulmonary embolism or deep vein thrombosis, and shortness of breath, finds a study today in JAMA Network Open.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Maine, which has confirmed only four monkeypox cases, today reported a case of the virus in a resident under the age of 18. No further details were released by the Maine Centers for Disease Control. Maine now joins California and Florida as states with pediatric cases.
Also, researchers in Spain detail a possible human-to-dog case.
Despite concerns, US officials press ahead with intradermal injection strategy amid rising cases.
The CDC also revised its school guidance, which no longer recommends cohorting or the test-to-stay strategy for exposed contacts.
In kids, lingering symptoms often occurred after mild illness and were more common in unvaccinated youngsters.
A survey of tuberculosis (TB) treatment centers in Europe found the availability of drug susceptibility testing (DST) for new and repurposed TB drugs in Europe is severely limited, drugs and regimens for drug-resistant TB are limited, and treatment costs for drug-resistant TB are very high, according to a study published this week in Clinical Microbiology and Infection.
Adults with blindness and deafness were less likely to be vaccinated against COVID-19, according to a large study of adults published today in an early online edition of JAMA Ophthalmology.
Japan reported a record daily high today, and South Korea's daily total reached a 4-month high.
More durable protection would be an advantage, since frequent mRNA vaccine boosting may be hard to sustain long-term.
One day after the United States said it would allow intradermal, fractional dosing of Bavarian Nordic's monkeypox vaccine, Jynneos, the World Health Organization (WHO) called for more trials on the practice.
Data from a healthcare-associated infection (HAI) surveillance network in India shows high rates of bloodstream and urinary tract infections (UTIs) and very high levels of antibiotic resistance, researchers reported in The Lancet Global Health.
As part of the push, the CDC began sending clinicians educational materials on how to administer intradermal vaccines.
The findings suggest newborns in low- and middle-income countries acquire resistance genes within hours of birth.
BA.4.6 levels are highest the Midwest region that includes Iowa, Kansas, Missouri, and Nebraska.
The authors say the findings underscore maxminizing vaccine coverage and consideration of boosters for teens, if research supports it.
In the first known estimate of the SARS-CoV spillover risk from bats to people, researchers who studied bat populations in South East Asia and interactions with humans estimate that about 66,280 people a year are infected each year. The team, based at EcoHealth Alliance, published their findings today in Nature Communications.
In other new developments, a preprint study found a low percentage of breakthrough infections in vaccinated people, and Israel reported an apparent infection from healthcare exposure.